Karuna Therapeutics (KRTX) Short Interest Ratio & Short Volume → The CHIPS Act Motherlode (From True Market Insiders) (Ad) Free KRTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Karuna Therapeutics Short Interest DataCurrent Short Volume1,970,000 sharesPrevious Short Volume2,110,000 sharesChange Vs. Previous Month-6.64%Dollar Volume Sold Short$618.52 millionShort Interest Ratio / Days to Cover2.3Last Record DateFebruary 29, 2024Outstanding Shares38,148,000 sharesPercentage of Shares Shorted5.16%Today's Trading Volume5 sharesAverage Trading Volume832,048 sharesToday's Volume Vs. Average0% Short Selling Karuna Therapeutics ? Sign up to receive the latest short interest report for Karuna Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKRTX Short Interest Over TimeKRTX Days to Cover Over TimeKRTX Percentage of Float Shorted Over Time Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. Karuna Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20241,970,000 shares $618.52 million -6.6%N/A2.3 $313.97 2/15/20242,110,000 shares $673.91 million +24.9%N/A2.5 $319.39 1/31/20241,690,000 shares $529.68 million +15.8%N/A2.1 $313.42 1/15/20241,460,000 shares $462.46 million -4.6%N/A2 $316.75 12/31/20231,530,000 shares $484.26 million -24.3%N/A2.5 $316.51 12/15/20232,020,000 shares $443.94 million -1.5%N/A4.7 $219.77 Get the Latest News and Ratings for KRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Karuna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/20232,050,000 shares $391.98 million +7.3%N/A7.7 $191.21 11/15/20231,910,000 shares $328.06 million +3.8%N/A8.1 $171.76 10/31/20231,840,000 shares $306.56 million +12.2%N/A7.7 $166.61 10/15/20231,640,000 shares $280.46 million -1.8%N/A6.5 $171.01 9/30/20231,670,000 shares $282.38 million +18.4%N/A6.6 $169.09 9/15/20231,410,000 shares $255.07 million +4.4%N/A5.3 $180.90 8/31/20231,350,000 shares $253.48 million -6.9%N/A3.9 $187.76 8/15/20231,450,000 shares $260.26 million +16.0%N/A4 $179.49 7/31/20231,250,000 shares $249.71 million -1.6%N/A3.3 $199.77 7/15/20231,270,000 shares $269.01 million -4.5%N/A3.3 $211.82 6/30/20231,330,000 shares $288.41 million -37.0%N/A3.3 $216.85 6/15/20232,110,000 shares $503.34 million -0.9%N/A5 $238.55 5/31/20232,130,000 shares $482.55 million +2.4%N/A5.2 $226.55 5/15/20232,080,000 shares $479.69 million -2.4%N/A5 $230.62 4/30/20232,130,000 shares $422.68 million +1.4%N/A5.1 $198.44 4/15/20232,100,000 shares $383.54 million -1.9%N/A5.2 $182.64 3/31/20232,140,000 shares $388.71 million +22.3%N/A5.5 $181.64 3/15/20231,750,000 shares $327.37 million +0.6%N/A4.8 $187.07 2/28/20231,740,000 shares $346.99 million +4.2%6.1%5.8 $199.42 2/15/20231,670,000 shares $324.23 million No Change5.9%5.8 $194.15 1/31/20231,670,000 shares $332.98 million -0.6%6.0%5.8 $199.39 1/15/20231,680,000 shares $337.26 million -2.9%6.0%5.7 $200.75 12/30/20221,730,000 shares $339.95 million +10.9%6.3%5.8 $196.50 12/15/20221,560,000 shares $312 million +6.1%5.6%4.8 $200.00 11/30/20221,470,000 shares $345.91 million -13.5%5.4%4.1 $235.31 11/15/20221,700,000 shares $392.31 million +4.9%6.2%4.8 $230.77 10/31/20221,620,000 shares $355.33 million No Change6.2%3.6 $219.34 10/15/20221,620,000 shares $333.56 million +14.9%6.4%3 $205.90 9/30/20221,410,000 shares $317.15 million -23.4%5.6%2.7 $224.93 9/15/20221,840,000 shares $449.07 million -1.1%7.3%3.5 $244.06 8/31/20221,860,000 shares $474.41 million -9.7%7.6%3.6 $255.06 8/15/20222,060,000 shares $563.84 million +36.4%8.4%4.2 $273.71 7/31/20221,510,000 shares $196.68 million +6.3%7.0%3.8 $130.25 7/15/20221,420,000 shares $191.97 million +5.2%6.6%4.7 $135.19Bible Shocker: Have You Seen Elon Musk’s Miracle? (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story… KRTX Short Interest - Frequently Asked Questions What is Karuna Therapeutics' current short interest? Short interest is the volume of Karuna Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 29th, traders have sold 1,970,000 shares of KRTX short. Learn More on Karuna Therapeutics' current short interest. What is a good short interest ratio for Karuna Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KRTX shares currently have a short interest ratio of 2.0. Learn More on Karuna Therapeutics's short interest ratio. Which institutional investors are shorting Karuna Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Karuna Therapeutics: Walleye Trading LLC, and PEAK6 Investments LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Karuna Therapeutics' short interest increasing or decreasing? Karuna Therapeutics saw a decrease in short interest in the month of February. As of February 29th, there was short interest totaling 1,970,000 shares, a decrease of 6.6% from the previous total of 2,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Karuna Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Karuna Therapeutics: Sarepta Therapeutics, Inc. (6.02%), United Therapeutics Co. (9.42%), Viatris Inc. (3.84%), Dr. Reddy's Laboratories Limited (0.52%), Catalent, Inc. (3.67%), BioMarin Pharmaceutical Inc. (2.06%), BeiGene, Ltd. (1.93%), Roivant Sciences Ltd. (8.27%), Elanco Animal Health Incorporated (2.73%), Legend Biotech Co. (7.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Karuna Therapeutics stock? Short selling KRTX is an investing strategy that aims to generate trading profit from Karuna Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Karuna Therapeutics? A short squeeze for Karuna Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KRTX, which in turn drives the price of the stock up even further. How often is Karuna Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRTX, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: Sarepta Therapeutics Short Interest United Therapeutics Short Interest Viatris Short Interest Dr. Reddy's Laboratories Short Interest Catalent Short Interest BioMarin Pharmaceutical Short Interest BeiGene Short Interest Roivant Sciences Short Interest Elanco Animal Health Short Interest Legend Biotech Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KRTX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders41 banks launch ‘crypto dollar’Stansberry ResearchClaim Your Complimentary Bitcoin RewardCrypto Swap Profits